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G-protein–coupled receptor (GPCR) heterodimers are new targets for the treatment of
schizophrenia. Dopamine D2 receptors and serotonin 5-HT1A and 5-HT2A receptors
play an important role in neurotransmission and have been implicated in many human
psychiatric disorders, including schizophrenia. Therefore, in this study, we investigated
whether antipsychotic drugs (clozapine (CLZ) and haloperidol (HAL)) affected the
formation of heterodimers of D2–5-HT1A receptors as well as 5-HT1A–5-HT2A receptors.
Proximity ligation assay (PLA) was used to accurately visualize, for the first time, GPCR
heterodimers both at in vitro and ex vivo levels. In line with our previous behavioral
studies, we used ketamine to induce cognitive deficits in mice. Our study confirmed
the co-localization of D2/5-HT1A and 5-HT1A/5-HT2A receptors in the mouse cortex.
Low-dose CLZ (0.3 mg/kg) administered repeatedly, but not CLZ at 1 mg/kg, increased
the level of D2–5-HT1A and 5-HT1A–5-HT2A heterodimers in the mouse prefrontal and
frontal cortex. On the other hand, HAL decreased the level of GPCR heterodimers.
Ketamine affected the formation of 5-HT1A–5-HT2A, but not D2–5-HT1A, heterodimers.
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INTRODUCTION
It is well established that dopamine D2 receptors and serotonin 5-HT1A and 5-HT2A receptors
play an important role in neurotransmission and that alterations in their functioning are
implicated in many human neurological and psychiatric disorders, including schizophrenia.
For a long time, prominent focus has been placed on the antipsychotic effects of D2 receptor
blockade (in the extended striatum), which alleviates the positive symptoms of schizophrenia.
Only since the 1990s has there emerged an appreciation of the effects of atypical antipsychotic
medications, which can be beneficial for the negative (cognitive) symptoms via combined action
at dopamine as well as serotonin and other classes of neuroreceptors (Newman-Tancredi and
Kleven, 2011). Considerable evidence has indicated that it is actually the balance between the
properties of D2 receptors and 5-HT1A receptors that has a profound influence on the profile of
action of these drugs in preclinical models (Newman-Tancredi, 2010); however, these actions are
also influenced by additional interactions at other receptor subtypes, such as 5-HT2A/5-HT2C,
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metabotropic glutamate receptor2/3 (mGluR2/3), and N-methyl-
d-aspartate (NMDA) receptor (Gaur et al., 2008; Meltzer and
Huang, 2008; Meltzer and Massey, 2011; Herrick-Davis, 2013;
Łukasiewicz et al., 2016).
Clozapine (CLZ), an antipsychotic drug currently used in the
clinic but still being the object of basic studies designed to search
for its unique molecular features, has been also shown to act via
various heterodimers. However, these studies have used in vitro
systems (cell lines transfected with recombinant receptors) and
sophisticated technology based on fluorescence resonance energy
transfer. It has been shown that CLZ uncouples dopamine D1–D2
receptor heterodimers (Faron-Górecka et al., 2008) and that
the effect is dependent on the concentration of CLZ as well as
on the incubation time. Łukasiewicz et al. (2011) demonstrated
the influence of CLZ and haloperidol (HAL) as well as other
antipsychotic compounds on D2–5-HT2A dimerization and on
alterations of the pharmacological properties of D2–5-HT2A
heterodimers. Moreover, the affinity of D1 and 5-HT2A receptors
for CLZ depends on whether they are present in the plasma
membrane separately or together with the D2 receptor (Faron-
Górecka et al., 2008; Łukasiewicz et al., 2011). In another
in vitro study, the D2 receptor was able to form constitutive
heterodimers with another serotonin receptor, 5-HT1A, and
CLZ significantly increased this interaction (Łukasiewicz et al.,
2016). Therefore, in the present study, we investigated whether
CLZ, administered to mice acutely or repeatedly in two doses,
affected the formation of heterodimers of dopamine D2–5-HT1A
receptors as well as 5-HT1A–5-HT2A receptors. For development
the cognitive deficit we used ketamine (KET) as tool substance,
according to our previous publication which showed that
CLZ dose-dependently reversed KET-induced cognitive deficits
(Szlachta et al., 2017). The method of choice to study endogenous
G-protein–coupled receptor (GPCR) interaction in the native
tissue is the in situ proximity ligation assay (PLA; Trifilieff
et al., 2011; Perreault et al., 2016; Borroto-Escuela et al.,
2017b; Szafran-Pilch et al., 2017). PLA was used to accurately
visualize the heterodimers both in vitro and in ex vivo mouse
brain.
MATERIALS AND METHODS
Our study was approved by the Bioethical Committee II at the
Institute of Pharmacology, Polish Academy of Sciences, Kraków,
Smetna 12, Poland (Number of Bioethical approval: #1196). The
experiments were carried out in accordance with the Bioethical
Committee.
Animals
Male C57Bl/6J mice (approximately 26 g and 11 weeks of age)
were purchased from Charles River, Germany. Mice were housed
in a room with a 12-h light-dark cycle (lights on at 07:30),
constant temperature (21 ± 2◦C), and humidity (40%–50%)
conditions in standard laboratory cages. Mice were housed 5 per
cage with mild food deprivation (2.9 g of food pellets per day)
and ad libitum access to water. Food deprivation and housing
schedule were based on our previous behavioral experiments
(Szlachta et al., 2017). However, mice used in biochemical studies
were not included in behavior experiments (they constituted a
separate group of animals).
Chemicals
KET (10% aqueous solution of 115.34 mg/mL, Biowet, Poland)
was dissolved in saline (SAL) to a concentration of 100 mg/kg.
CLZ (Tocris, UK) was dissolved in 1M hydrochloric acid and
then diluted in SAL. NaOH solution was added to buffer the
solution to ∼pH 6.5–7.0. HAL (SAL solution of 5 mg/kg, Polfa
Warszawa S.A, Poland) was diluted in SAL. Experiments were
carried out using two different paradigms: acute and sub-chronic
administration. For the acute paradigm, drugs (SAL, KET and/or
CLZ at 0.3 mg/kg; intraperitoneally [i.p.]) were administered
twice (second administration was 24 h after the first one) and
mice were decapitated 1 h after the second injection. This
experimental paradigm resulted from the scheme of our previous
behavioral studies (Szlachta et al., 2017). For the sub-chronic
paradigm, drugs (KET or SAL) were repeatedly administered
(i.p.) for seven consecutive days, followed by replacement with
CLZ (0.3 or 1 mg/kg; i.p.) or HAL (0.1 mg/kg; i.p.) for the
next 7 days. All injections were done once per day during
this period. Mice were sacrificed 24 h after the last drug
administration.
Tissue Preparation
The brains were isolated from decapitated animals and ra pidly
frozen on dry ice. Coronal brain sections (5 µm thicknes
for PLA technique and 12 µm thickness for autoradiography
experimemnts) were cut using a Jung CM 3000 cryostat
microtome (Leica, Germany) by a standard procedure. The
slices were thaw-mounted on gelatin-covered microscope slides,
air-dried, and stored at −20◦C until use. Brain sections were
identified according to The Mouse Brain Atlas (Paxinos and
Franklin, 2001). Coronal slides were taken approximately at
2.68 mm Bregma and 0.98 mm Bregma.
[3H]Domperidone Binding to Dopamine D2
Receptors and Analysis of Autoradiograms
Tissue sections were pre-incubated in phosphate buffer
(pH 7.4) at room temperature for 15 min to rehydrate
the tissue sections and to remove potential endogenous
dopamine. Brain slices were incubated for 90 min at room
temperature in phosphate buffer (pH 7.4) with addition of
10 mM MgCL2 and 150 mM KCl containing 0.4 nM tritium-
labeled domperidone ([3H]domperidone). [3H]domperidone
concentration refers to the dissociation constant (Kd value)
for the [3H]domperidone-dopamine D2 receptor (Knable
and Weinberger, 1997; Krystal et al., 1999; Seeman et al.,
2003; Z˙ urawek et al., 2013). To determine non-specific
binding, parallel tissue sections from the same animals were
incubated in the same buffer as described above, enriched
with 10 µM (+) butaclamol for 90 min at room temperature.
After incubation, tissue sections were washed three times in
ice-cold phosphate buffer (pH 7.4) for 10 min and once in
ice-cold distilled water for 1 min. The sections were dried
overnight under a gentle stream of air. The radiolabeled
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brain slices were loaded into a FujiFilm BAS Cassette and
placed against a Fuji Imaging Plate (Fujifilm, Japan) with
autoradiographic microscales (GE Healthcare) for 7 days. The
obtained autoradiograms were analyzed and quantified using
ImageGauge software (Fujifilm, Japan). The specific binding
of radioligand to D2 receptor was calculated by subtracting
non-specific binding images in adjacent brain slices from the
total binding signal.
[3H]8-OH-DPAT Binding to 5-HT1A
Receptors and Analysis of Autoradiograms
Brain slices were pre-incubated in 50 mM Tris–HCl buffer
(pH 7.4) enriched with 120 mM NaCl, 4 mM CaCl2, and
0.01% ascorbic acid at room temperature for 15 min to
rehydrate the tissue sections and to remove potential endogenous
serotonin. Incubation buffer was the same as pre-incubation
buffer but contained additionally 2 nM [3H]8-OH-DPAT. The
tissue sections were incubated in that buffer for 60 min at
room temperature to determine total binding. [3H]8-OH-DPAT
concentration corresponded to the Kd value (Schiller et al.,
2003). Parallel sections treated with 10 µM serotonin were
incubated in the incubation buffer with 2 nM [3H]8-OH-
DPAT to determine non-specific binding for 60 min at room
temperature. Incubation was terminated by washing the slices
twice in ice-cold 50 mM Tris–HCl (pH 7.4) enriched with
120 mM NaCl, 4 mM CaCl2, and 0.01% ascorbic acid for 10 min
and once in ice-cold distilled water for 1 min. The sections
were dried overnight under a gentle stream of air. Imaging and
analysis of autoradiograms were carried out in the same way as in
the case of [3H]domperidone binding to D2 receptors described
above.
[3H]Ketanserin Binding to 5-HT2A
Receptors and Analysis of Autoradiograms
To remove endogenous serotonin and to rehydrate the tissue
sections, brain sections were pre-incubated in 50 mM Tris–HCl
buffer (pH 7.4) enriched with 120 mM NaCl and 4 mM
CaCl2 for 15 min at room temperature. To determine total
binding, slides were incubated in the pre-incubation buffer
supplemented with 2 nM [3H]ketanserin for 60 min at room
temperature. [3H]ketanserin concentration refers to the Kd
value for the [3H]ketanserin-serotonin 5-HT2A receptor binding
(Schiller et al., 2003). The buffer used in the incubation step
was enriched with 10 µM mianserin to define non-specific
binding and parallel brain sections were incubated in that buffer
for 60 min at room temperature. Tissue sections were washed
twice in ice-cold 50 mM Tris–HCl buffer (pH 7.4) for 10 min
and once in ice-cold distilled water for 1 min, and then dried
overnight under a gentle stream of air. Imaging and analysis of
autoradiograms were carried out in the same way as described
above.
Immunohistochemistry on
Paraffin-Embedded Tissue Sections
To co-localize D2/5-HT1A receptors and 5-HT1A/5-HT2A
receptors in the brain, mouse brain was fixed in 4% formaldehyde
for overnight, then embedded in paraffin blocks and sectioned
using a microtome. To stain D2, 5-HT1A, and 5-HT2A
receptors, anti-D2 receptor antibody (H-50, sc-9113, Santa Cruz
Biotechnology, Inc.; 1:50 dilution), anti-SR-1A antibody (C-19,
sc-1459, Santa Cruz Biotechnology, Inc.; 1:50 dilution), and anti-
5-HT2A receptor antibody (ab66049, Abcam; 1:200 dilution)
were used, respectively. Dilutions of secondary antibodies
(Alexa Fluor 488 Donkey anti-Rabbit IgG, ref. A21206;
Alexa Fluor 555 Donkey anti-Goat IgG, ref.A21432; Alexa
Fluor 555 Donkey anti-Rabbit IgG, ref. A31572; Invitrogen)
were prepared in 5% NDS in concentration 1:100 in all
cases. Imaging was done by fluorescence microscope (Zeiss
Axio Imager. A2, Poland) using a 20× objective and the
following excitation wavelengths: 563 nm for 5-HT1A receptor,
490 nm for D2R and 5-HT2A receptor, and 358 nm for
DAPI.
Proximity Ligation Assay (PLA)
To determine receptor interaction in native tissue, PLA was
used (Söderberg et al., 2008; Borroto-Escuela et al., 2013, 2014;
Perreault et al., 2016). The method uses the proximity probes,
composed of oligonucleotide-conjugated secondary antibodies,
to recognize specific targets. Close proximity of targets allow for
binding of probes, their hybridization, and subsequent formation
of a circular DNA strand. Addition of polymerase in the next
step leads to amplification of these DNA circles via polymerase
chain reaction. The signal from each detected pair of proteins is
visualized as an individual fluorescent spot.
PLA was performed according to the manufacturer’s protocol
of the Duolink in situ PLA Probes and Duolink in situ
Detection Reagents Orange kit (Cat. No. DUO92007 and
Cat. No. DUO92008, respectively). According to Szafran-
Pilch et al. (2017), brain sections of 5 µm thickness were
used in PLA method. Antibodies, the same as used in
immunohistochemistry, were dissolved in Antibody Diluent in
concentration 1:100. For imaging, the slides were dried and
mounted with a cover slip using∼7 µl Duolink in situ Mounting
Medium with DAPI. Imaging and analysis of labeled brain
sections was done with a fluorescence microscope (Zeiss Axio
Imager. A2, Poland) using a 40× objective and excitation
wavelength 563 nm for PLA and 358 nm for DAPI. From each
coronal brain sections, four measurements in the prefrontal
cortex and the frontal cortex were obtained. Each image
was analyzed using microscope software to count individual
fluorescent spots. Calculating a number of fluorescent spots
was based on the measurement of intensity fluorescence level.
Threshold for fluorescence intensity measurement was set
manually, but calculations were done automatically by the
software.
Statistical Analysis
Raw data were analyzed using two-way analysis of variance
(ANOVA) with Bonferroni post-test to compare all groups
of the experiments. Results from the specific binding of all
three radioligands as well as results from the PLA assay were
normalized to the data of the control group (expressed as 100%).
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RESULTS
[3H]Domperidone Binding to Dopamine D2
Receptors and Analysis of Autoradiograms
Radioligand binding determination to dopamine D2 as well as
serotonin receptors (5HT1A and 5HT2A) using autoradiography
was done before PLA experiments to exclude possibility that
changes in receptors dimerization level resulted from drug
influence on receptors density. Representative autoradiograms
of the distribution of [3H]domperidone-binding sites in the
prefrontal cortex and frontal cortex of the mouse brain are
presented in Figure 1A. Analysis of [3H]domperidone binding
to dopamine D2 receptors in prefrontal cortex and frontal
cortex in mouse brain did not show any significant differences
after acute treatment of CLZ in dose 0.3 mg/kg (Figure 1B).
In acute administration paradigm, only one dose of CLZ was
used in line with our previous behavioral studies (Szlachta
et al., 2017). Sub-chronic treatment of mice revealed increase
in specific [3H]domperidone-binding sites in prefrontal cortex
after treatment KET + CLZ 1 mg/kg in comparison to mice
group treated SAL + CLZ 1 mg/kg (Figure 1C). However, KET
+ HAL caused decrease in D2 receptors density in relation
to the KET + SAL group in the prefrotal cortex. Analysis of
radioligand binding to dopamine D2 receptor in frontal cortex
did not show any significant differences after treatment of all
using antipsychotic drugs (Figure 1C).
[3H]8-OH-DPAT Binding to Serotonin
5-HT1A and Analysis of Autoradiograms
Distribution of [3H]8-OH-DPAT binding to 5-HT1AR is
presented in Figure 2A. Analysis of 5-HT1A receptor density in
mice receiving antipsychotic drugs in acute treatment paradigm
did not indicate any significant differences in radioligand
binding in prefrontal and frontal cortex (Figure 2B). In repeated
administration, significant KET impact on [3H]8-OH-DPAT
binding to 5-HT1AR in the prefrontal cortex was observed.
Groups of mice receiving KET during first 7 days were
characterized by higher density of 5-HT1AR in comparison
to experimental group treated SAL for 7 days followed by
replacement with antipsychotic drugs (Figure 2C). In frontal
cortex, only sub-chronic treatment of KET + HAL 0.1 mg/kg
induced a significant increase of [3H] 8-OH-DPAT binding to
5-HT1A receptors in relation to SAL + HAL 0.1 mg group
(Figure 2C).
[3H]Ketanserin Binding to Serotonin
5-HT2A Receptors and Analysis of
Autoradiograms
Representative autoradiograms of the distribution of
[3H]ketanserin binding to serotonin 5-HT2A receptors in
the mouse prefrontal cortex and frontal cortex are showed
in Figure 3A). Acute treatment of mice did not cause any
significant changes in density of serotonin 5-HT2A receptors
in mouse prefrontal and frontal cortex (Figure 3B). Analysis
of [3H]ketanserin binding to serotonin 5-HT2A receptors in
mouse frontal cortex after repeated drug administration releaved
significant impact of CLZ 1 mg/kg treatment, while the HAL
treatment did not have any significant impact (Figure 3C).
Statistical analysis concerning prefrontal cortex did not indicate
any significant drug’s effect on abundance of serotonin 5-HT2A
receptors (Figure 3C).
Co-localization of D2 Receptors and
5-HT1A Receptors in the Mouse Brain
Cortex
In order to determine whether D2 and 5-HT1A receptors as
well as 5-HT1A and 5-HT2A receptors can directly interact with
each other, we studied the co-localization of the following pairs
receptors: D2/5-HT1A and 5-HT1A/5-HT2A in mouse brain using
immunohistochemistry and fluorescence microscopy.
The obtained data indicated that dopamine D2 receptors
co-localized with 5-HT1A receptors and that 5-HT1A co-localized
with 5-HT2A receptors in the mouse cortex (Figures 4A,B,
respectively). All required positive and negative controls were
done indicating that used antibodies are specific (data not
shown). Antibodies were chosen based on literature (Ramírez
et al., 2009; Noga et al., 2009; Yeung et al., 2010; Merlo et al., 2011;
Hooper et al., 2016; Xiao et al., 2016). Moreover, we checked the
specificity of antibodies by Western Blot, where different levels
of receptors protein in different mouse brain structures were
observed (data not shown).
Control of PLA Technique
Antibody selection was preceded first in single recognition
experiment follow by double recognition assay according to PLA
method protocol (data not shown). To determine the method
specificity, PLA was performed on mouse cortex neurons. Cells
from the mouse cortex were isolated as described previously
(Brewer and Torricelli, 2007). On day 7 of cells culture, cells
were incubated with 10 µM dopamine for 3 h. Dopamine leads
to internalization of D2 receptors (Bartlett et al., 2005) and
helps determine the specificity of the PLA signal. As a result
of the internalization of the dopamine D2 receptors at 10 µM
concentration of dopamine, we observed a decrease of interaction
between the 5-HT1A–D2 receptors (Figure 5C). Figures 5A,B
showed fluorescence images in which difference in interaction
between the 5-HT1A–D2 receptors in mouse visible as different
level of PLA signal was observed. Moreover, to authenticate
PLA method, we showed image from corpus callosum where
PLA signal was not observed, which confirm specificity of PLA
methods as well as antibodies (Figure 5D).
Interaction of D2 and 5-HT1A Receptors
The method of choice to study endogenous GPCR heteromers
in the native tissue is the in situ PLA. The most popular format
of this technique uses a pair of receptor-specific antibodies from
different species, which are recognized by secondary antibodies
with attached oligonucleotides. When the probes recognize
the target, the attached oligonucleotides are then localized
at a sufficiently close distance (less than 40 nm); proximity-
dependent ligation forms a circular DNA template, which is
thereafter amplified via rolling circle amplification. The product
is visualized with a fluorescently labeled probe.
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FIGURE 1 | Effect of clozapine (CLZ) and haloperidol (HAL) treatment on specific binding of [3H]domperidone to dopamine D2R. (A) Representative autoradiograms
of the total [3H]domperidone binding in mouse prefrontal cortex (a); non-specific binding of [3H]domperidone in prefrontal cortex (b); total [3H]domperidone binding
in mouse frontal cortex (c); non-specific binding of [3H]domperidone in frontal cortex (d). (B) Acute administration of CLZ 0.3 mg/kg did not affect on density D2
receptor level in prefrontal and frontal cortex. (C) For repeated treatment, two-way analysis of variance (ANOVA; SAL, KET) × (SAL, CLZ 0.3 mg/kg, CLZ 1 mg/kg)
revealed a significant interaction between KET and CLZ (F(2,23) = 7.139; p < 0.01) as well as statistical analysis (SAL, KET) × (SAL, HAL) indicated a significant
effects caused by HAL (F(1,14) = 14.73; p < 0.05) and KET (F(1,14) = 6.351; p < 0.01) on [3H]domperidone binding to D2 receptors in the prefrontal cortex. In the
frontal cortex, using two-way ANOVA no significant effect was observed after sub-chronic drug’s treatment. The post hoc analysis revelead the statistical significant
differences between: CLZ 1 mg/kg and KET + CLZ 1 mg/kg groups, ∗p < 0.05 and between KET 20 mg/kg and KET+HAL 0.1 mg/kg groups, $p < 0.05. The
control data were standardized to 100%. The data represent the mean ± SEM.
Representative fluorescence images indicating D2 and 5-
HT1A receptor interaction is shown in Figure 6A. Figure 6B
represents image after analysis done by microscope software
assessing interaction level of D2R and 5-HT1AR in selected
mouse brain regions. In prefrontal cortex, lower dose of
CLZ (0.3 mg/kg) given acutely increased the level of D2–5-
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FIGURE 2 | Effect of CLZ and HAL treatment on specific binding of [3H]8-OH-DPAT to 5HT1AR. (A) Representative autoradiograms of the total [3H] 8-OH-DPAT
binding in mouse prefrontal cortex (a); non-specific binding of [3H] 8-OH-DPAT in prefrontal cortex (b); total [3H] 8-OH-DPAT binding in mouse frontal cortex (c);
non-specific binding of [3H]8-OH-DPAT in frontal cortex (d). (B) Two-way ANOVA (SAL, KET) × (SAL, CLZ 0.3 mg/kg) did not show any significant differences in [3H]
8-OH-DPAT binding determined in the prefrontal and frontal cortex after acute CLZ treatment. (C) Repeated treatment by CLZ in two doses (0.3 mg/kg and 1 mg/kg)
caused significant KET impact on [3H]8-OH-DPAT binding to 5-HT1AR in the prefrontal cortex (F(1,27) = 6.381; p < 0.05), however, in the frontal cortex, no significant
differences were observed. For sub-chronic HAL administration, two-way ANOVA analysis (SAL, KET) × (SAL, HAL) revealed also a significant effect of KET on the
[3H]8-OH-DPAT binding in the prefrontal cortex and frontal cortex (F(1,13) = 6, 609; p < 0.05 and F(1,9) = 17.8; p < 0.01, respectively). The post hoc analysis
revelead the statistical significant differences between KET+HAL 0.1 mg/kg vs. KET 20 mg/kg groups in frontal and prefrontal cortex, $p < 0.05. The control data
were standardized to 100%. The data represent the mean ± SEM.
HT1A receptor interaction in comparison to control group
(Figure 6C). Analysis of PLA signal level in mouse frontal cortex
indicated significantly lower D2–5-HT1A receptor interaction
in experimental groups: 1× KET and 1× KET + CLZ 0.3 mg
(Figure 6C). Sub-chronic treatment of CLZ at 0.3 mg/kg
increased the PLA signal but repeated administration of HAL led
to decrease in D2–5-HT1A receptor interaction, in comparison to
control group in prefrontal cortex (Figure 6D). Similarly to the
prefrontal cortex, CLZ 0.3 mg/kg administered sub-chronicaly
increased the level of D2–5-HT1A receptor interaction in the
brain frontal cortex, in contrast to HAL which caused decrease
in the interaction of this pair of receptors (Figure 6D).
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FIGURE 3 | Effect of CLZ and HAL treatment on specific binding of [3H]ketanserin to 5HT2AR. (A) Representative autoradiograms of the total [3H]ketanserin binding
in mouse prefrontal cortex (a); non-specific binding of [3H]ketanserin in prefrontal cortex (b); total [3H]ketanserin binding in mouse frontal cortex (c); non-specific
binding of [3H]ketanserin in frontal cortex (d). (B) Two-way ANOVA (SAL, KET) × (SAL, CLZ 0.3 mg/kg) did not show any significant alterations in [3H]ketanserin
binding determined in the prefrontal and frontal cortex. (C) For repeated administration, statistical analysis concerning prefrontal cortex did not indicate any
significant drug’s effect on abundance of serotonin 5-HT2A receptors. Two-way ANOVA (SAL, KET) × (SAL, CLZ 0.3 mg/kg, CLZ 1 mg/kg) and (SAL, KET) × (SAL,
HAL) revealed a significant impact of CLZ (F(2,22) = 4.290; p < 0.05), while the HAL treatment did not have any significant impact on the [3H]ketanserin binding in the
brain frontal cortex. The control data were standardized to 100%. The data represent the mean ± SEM.
Interaction of 5-HT1A and 5-HT2A
Receptors
Figure 7A represents an image of serotonin 5-HT1A–5-HT2A
interaction in the mouse brain. Figure 7B shows image after
computer analysis of determined PLA signal level. In brain of
mouse treated in acute paradigm, any significant alterations
in receptors interaction level was not observed (Figure 7C).
Analysis of serotonin 5-HT1A–5-HT2A receptor interaction in
the PFC after chronic treatment showed a significant effect
of KET and CLZ 0.3 mg/kg. In all KET receiving groups as
well as in SAL + CLZ 0.3 mg/kg group, an increase in PLA
signal for 5-HT1A–5-HT2A receptors was observed in the PFC,
in comparison to control group (Figure 7D). In the brain
frontal cortex, repeated treatment SAL + CLZ 0.3 mg/kg induced
increase in serotonin 5-HT1A–5-HT2A receptor interaction
(Figure 7D).
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FIGURE 4 | Immunohistochemical detection of co-localization of the 5HT1AR with D2R or 5HT2AR in mice frontal cortex. (A) Representative images of
double-immunofluorescent staining for dopamine D2R (green) and serotonin 5HT1AR (orange) in the mouse cortex—merged (yellow). Scale bar: 20 µm.
(B) Representative images of double-immunofluorescent staining for 5HT2AR (green) and serotonin 5HT1AR and (orange) in the mouse cortex—merged (yellow).
Scale bar: 20 µm. White arrows indicated membrane localization and co-localization of studied receptors.
DISCUSSION
The main finding of this manuscript is the demonstration
that the GPCR interaction can be important in the action of
KET and CLZ.
It seems especially important in the field of antipsychotic
drugs, which are effective in the clinic but induce adverse side
effects. One such drug is CLZ, which shows a wide receptors
profile. CLZ is classified as atypical neuroleptic because of affinity
to serotonin receptors; its affinity for 5-HT2AR is greater than
for D2R (Meltzer, 1999). It has been shown that CLZ has a
high in vitro affinity for 5-HT2A receptor and behaves as partial
agonist in vivo at 5-HT1AR (Kargieman et al., 2012). With
their moderate in vitro affinity for 5-HT1A, CLZ and other
atypical antipsychotic drugs act as agonists at 5-HT1A receptor
in vivo to increase PFC dopamine release (Rollema et al., 1997;
Ichikawa et al., 2001; Díaz-Mataix et al., 2005; Bortolozzi et al.,
2010; Purkayastha et al., 2012). PFC plays a fundamental role
in higher brain functions and numerous observations suggest
an abnormal function of this cortical area in schizophrenia
(Goldman-Rakic, 1994; Knable and Weinberger, 1997; Edwards
et al., 2010). Moreover, the non-competitive NMDA receptor
antagonists, such as phencyclidine (PCP) or KET exacerbate
clinical symptoms in patients with schizophrenia and induce
behavioral alterations that resemble schizophrenia symptoms
in healthy individuals and experimental animals (Kargieman
et al., 2012). In our previously behavioral studies using ASST
test in mouse (Szlachta et al., 2017), we have demonstrated
that CLZ 0.3 mg/kg reverses the KET activity in the crucial
phase of this test. This effect was interpreted via the possible
specific action of this substance on serotonin and dopamine
heteromers. Because of this, the goal of our work was to
demonstrate that the molecular mechanism of the unique action
of CLZ is dependent on receptor heteromers. The present
study was performed using PLA technique, which enables to
monitor the dimerization of a given pair of receptors in the
mouse brain. In our previous study we observed in locomotor
activity test, that CLZ 1 mg/kg after acute treatment induced
sedation effects. Therefore, in this study, we also tested only
low-dose CLZ in acute paradigm treatment (Szlachta et al.,
2017).
The PLA experiments were preceded by the receptor
autoradiography (analysis on the same brain samples) in order
to determine whether the treatment of CLZ, HAL, or KET
influenced the levels of the studied receptors in the PFC and
frontal cortex.
The interaction between receptors is possible only when they
co-localize therefore we first confirmed that indeed, 5-HT1A and
dopamine D2 receptors co-localize in the mouse PFC and frontal
cortex. The co-localization of 5-HT1A and D2 receptors was also
observed in the mouse PFC by Łukasiewicz et al. (2016).
In our study, we observed 5-HT1A–D2 physical interaction
in PFC and frontal cortex in mice. There is increasing interest
in antipsychotics intended to manage positive symptoms via
D2 receptor blockade and improve negative symptoms and
cognitive deficits via 5-HT1A receptor activation (Newman-
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FIGURE 5 | Control of specificity proximity ligation assay (PLA) assay. Representative fluorescence image of 5HT1AR-D2R PLA signal in mouse cortex neurons from
control group (A) and neurons incubated with 10 µM dopamine for 3 h (B). D2R internalization caused by dopamine decrease level of 5HT1AR-D2R interaction
measured using PLA assay. The control data were standardized to 100%. The data represent the mean ± SEM and were analyzed using unpaired t test ∗p < 0.05
(C). Fluorescence image showing lack of PLA signal which determine level of 5HT1AR-D2R interaction from corpus callosum indicating regional specificity PLA
method (D).
Tancredi and Kleven, 2011). In this context, we studied if
antipsychotic drugs affected the physical interaction of these
receptors. The functional consequences of the signaling pathways
mediated by 5-HT1A–D2 interaction are still not known in
detail. Łukasiewicz et al. (2016) indicated that upon incubation
of cells with antipsychotic drugs, different second messenger
pathways are activated depending on whether D2 and 5-HT1A
receptors are expressed alone or together (Łukasiewicz et al.,
2016). It is interesting that in our studies KET did not
influence the 5-HT1A–D2 interaction, whereas CLZ in low-dose
(0.3 mg/kg) increased the interaction of this pair of receptors
in the mouse brain. The impact of CLZ on the 5-HT1A–D2
heteromers confirms the results obtained in in vitro study by
Łukasiewicz et al. (2016). However, the scope of the present
research did not cover the functional significance of this
phenomenon, but it will certainly be a subject of further studies.
Interestingly, on autoradiographs, we did not observe any
changes in receptor density following KET or CLZ treatment. On
the other hand, administration of HAL significantly decreased
the density of dopamine D2R, so the decreased PLA signal
indicating the decreased receptor interaction observed after
HAL treatment might have resulted from the antagonist action
of this drugs on D2R. However, it is interesting that in
receptor autoradiography studies we observed the lower level
of 5-HT1AR following HAL administration and this effect was
reversed by KET pretreatment. Since the physical interaction
between 5-HT1A and NMDA receptors in the PFC has been
reported (Yuen et al., 2005) and HAL pretreatment reduces
impairments in cognitive function produced by KET (Krystal
et al., 1999) the mechanism of this interaction can be the
results of receptor dimerization. In our study, we treated mice
first with KET, and then with HAL. Hence, it is tempting
to suggest that earlier administration of KET might have
induced conformational changes in the binding site of the
5-HT1AR.
Recently, using PLA methodology, has been evidence for
the existence of brain 5-HT1A–5-HT2A isoreceptor complexes
validated in cellular models with bioluminescence resonance
energy transfer (BRET2) assay. The authors demonstrated the
existence of 5-HT1A–5-HT2A isoreceptor complexes in the dorsal
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FIGURE 6 | Effect of acute and sub-chronic antipsychotic drug’s treatment on the level of 5HT1AR-D2R interaction in mouse brain. Representative fluorescence
image of D2R and 5HT1AR interaction after acute treatment (A). Representative image after computer analysis of PLA signal 5HT1AR-D2R in mice frontal cortex (B).
For acute treatment experiments, two-way ANOVA (SAL, KET) × (SAL, CLZ 0.3 mg/kg) revealed significant impact of CLZ 0.3 mg on D2–5-HT1A receptor in the
prefrontal cortex (F(1,14) = 6.564, p < 0.05) (C). Statistical analysis (SAL, KET) × (SAL, CLZ 0.3 mg/kg) of PLA signals indicating D2–5-HT1A interaction in the brain
frontal cortex showed the influence of acute KET treatment (F(1,14) = 6.634; p < 0.05). The post hoc analysis revelead the significant difference between KET+CLZ
0.3 mg/kg and CLZ 0.3 mg/kg group, ∧p < 0.05. (C). Analysis of sub-chronic treatment on D2–5-HT1A receptor PLA signal (SAL, KET) × (SAL, CLZ 0.3 mg/kg, CLZ
1 mg/kg) and (SAL, KET) × (SAL, HAL) in a mouse brain tissue revealed significant effect of CLZ and HAL in the prefrontal cortex ((F(2,22) = 4.630; p < 0.05) and
(F(1,14) = 14.97; p < 0.05), respectively) The post hoc analysis revealed statistical significant changes between CLZ 0.3 mg/kg vs. SAL group, ∗p < 0.05 and
between HAL 0.1 mg/kg vs. SAL group, #p < 0.05 (D). Similairly, in mice frontal cortex, significant influence of CLZ and HAL sub-chronic administration on
5HT1AR-D2R interaction level was observed ((F(2,19) = 9.755; p < 0.05) and (F(1,13) = 24.73; p < 0.05), respectively). The post hoc analysis revealed statistical
significant changes between CLZ 0.3 mg/kg vs. SAL group, ∗p < 0.05 and between HAL 0.1 mg/kg vs. SAL group, ##p < 0.01 (D). The control data were
standardized to 100%. The data represent the mean ± SEM.
hippocampus and the anterior cingulate cortex (Borroto-Escuela
et al., 2017a). Both 5-HT1AR and 5-HT2AR are abundantly
expressed in rodent PFC (Pompeiano et al., 1992, 1994;
Santana et al., 2004), where they are mostly co-expressed
(Amargós-Bosch et al., 2004). They mediate opposing actions:
5-HT1AR is inhibitory, while 5-HT2AR is excitatory of 5-HT
and selective agonists (Araneda and Andrade, 1991; Marek and
Aghajanian, 1999; Amargós-Bosch et al., 2004; Puig et al., 2005).
It has been shown that 5-HT1AR and 5-HT2AR receptors mediate
the changes in cortical dopaminergic transmission induced by
atypical antipsychotic drug. Atypical neuroleptics via blockade
of 5-HT2AR and D2R, may promote the ability of 5-HT1AR
stimulation to increase PFC dopamine release (Ichikawa et al.,
2001; Celada et al., 2004). Therefore, we also studied this pair
of receptors in the context of potential dimerization. First, we
found the co-localization of these receptors in the mouse brain.
We observed the co-localization of 5-HT1AR and 5-HT2AR in
the mouse prefrontal cortex and frontal cortex. To the best of
our knowledge this is the first time observation in mice and it is
complementary to observation in rats by We˛dzony et al. (2008).
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FIGURE 7 | Effect of acute and sub-chronic antipsychotic drug’s treatment on the level of 5HT1A–5HT2A interaction in mouse brain. Representative fluorescence
image of D2R and 5HT1AR interaction after chronic treatment (A). Representative image after computer analysis of PLA signal 5HT1AR-D2R in mice frontal cortex (B).
Two-way ANOVA analysis (SAL, KET) × (SAL, CLZ 0.3 mg/kg) did not show any significant alterations in 5HT1A–5HT2A receptors interaction level in mice PFC and
frontal cortex after acute treatment (C). Statistical analysis of serotonin 5-HT1A–5-HT2A receptor interaction (SAL, KET) × (SAL, CLZ 0.3 mg/kg, CLZ 1 mg/kg) in the
prefrontal cortex after chronic CLZ treatment showed a significant effect of KET and CLZ (F(2,25) = 7.534; p < 0.05; F(1,25) = 14.08; p < 0.05; respectively).
Concerning HAL treatment, two-way ANOVA (SAL, KET) × (SAL, HAL) revealed also a significant impact of KET (F(1,12) = 5.953; p < 0.05). The post hoc analysis
revealed significant differences between: KET 20 mg/kg vs. SAL group, #p < 0.05 and between CLZ 0.3 mg/kg vs. SAL group, ∗p < 0.05, ∗∗p < 0.01 (D). In the
brain frontal cortex, statistical analysis (SAL, KET) × (SAL, CLZ 0.3 mg/kg, CLZ 1 mg/kg) and (SAL, KET) × (SAL, HAL) revealed significant influence of chronic CLZ’s
treatment on PLA signal level indicating serotonin 5-HT1A–5-HT2A receptor interaction (F(2,19) = 8.213; p < 0.05). The post hoc analysis revealed significant
difference between CLZ 0.3 mg/kg and SAL group, p < 0.05 (D). The control data were standardized to 100%. The data represent the mean ± SEM.
We were also able to observe the interaction between 5-HT1AR
and 5-HT2AR in the studied brain regions. The observation of
interaction between HT1A–5-HT2A it can be confirmed by results
obtained by Borroto-Escuela et al. (2017a). Intriguing finding in
current work is that KET had impact on the interaction of this
pair of receptors, while it did not affect the 5-HT1A–D2 receptor
interactions. This result was also independent of any changes
in receptors density (no changes in receptor autoradiography
using [3H]ketanserin and [3H]8-OH-DPAT). However, it has
been shown that KET exhibited a high affinity only for the
5-HT2AR and showed a much lower affinity for the low affinity
state of this receptor (Kapur and Seeman, 2002). In addition,
we have shown the effect of low-dose CLZ on 5-HT1A–5-HT2A
receptor interaction. KET and CLZ induced a synergistic effect,
whereas higher-dose CLZ had no effect. This difference is
puzzling; however, such phenomenon has been already observed
in our previous study on uncoupled dopamine D1–D2 receptor
heterodimers (Faron-Górecka et al., 2008). The results obtained
in the present study indicate that KET had an impact on
5-HT1A–5-HT2A receptor interaction, but they do not explain the
behavioral outcomes obtained in ASST. If the effect of CLZ in
KET-induced ASST test in mice was based on a specific action of
this receptor pairs, we should observe different (opposing) effect
of KET and CLZ on the formation of the studied pair of GPCR.
The results obtained by us in biochemical studies point to
the selective action of individual KET, CLZ, or HAL drugs on
the potential formation of heteromers, which may have impact
on further investigation not only of the unique action of CLZ
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but also of KET, an important drug not only in schizophrenia
but also in depression. However, we have to be aware, that
presented results demonstrate only antipsychotic impact on
receptors interaction but further research is required to prove
functional dimerization of GPCR.
Limitation of Studies
The best control of PLA methods specifity would be experiments
using knock-out mice. This approach let to assess what is the
level of PLA signal background without one of receptor and
then subtraction this background from experimental group.
Presented data lack such a control. But our studies include
the appropraite controls which in our opinion are sufficient
to state that PLA assay is reliable: (1) in vitro experiment
with 10 µM dopamine, inducing dopamine D2 receptors
internalization and PLA signal is decreased; (2) according
to literature, in corpus callosum, dopamine D2 receptors do
not exist and we did not observe any D2R-5HT1AR PLA
signal what proves method and antibody specificity; and
(3) single recognition experiment (PLA method used to assess
expression level of one protein) indicated the level of D2
receptors in the striatum twice as high as in the prefrontal
cortex.
Many control experiments also have been done which
confirmed antibodies specificity: (1) D2 receptors were not
expressed in all brain regions, i.e., D2 receptors expression
was observed in the brain cortex but was not observed in
the hippocampus; similarly, D2 receptors were not expressed
in all cortex layers but only in particular ones; (2) cellular
localization of D2 receptors and 5HT1A receptors determined by
our antibodies are different and signals from two antibodies were
not overlapped in all cells; not every cell which expressed D2
receptor also had 5HT1A receptor; and (3) images from single
recognition PLA experiment not show any background what
proves specificity of our antibody because according to Duolink
manufacturer’s protocol, when unspecific antibody is used, high
background is visibled, due to the sensitivity of the assay.
There is a discussion on the interpretation of results using
available techniques to observe the GPCRs interaction. It has
been shown that this phenomenom could activate the new
signaling pathways or lead to functional crosstalk (Albizu et al.,
2011; Ferré et al., 2014; Borroto-Escuela et al., 2016). Moreover
it has been raised that the GPCRs interaction studied in vitro
by FRET methods as well as in native tissue by PLA assay
determine only close distance between them (in case of PLA
method it is 17 Å), so these methods do not provide sufficient
evidence to talk about their direct physical interaction and
this is imprecise term. Due to currently available methods,
published articles regarding GPCRs heterodimerization indicate
that their interaction could lead to molecular crosstalk
between receptors and cause functional consequence rather
than their physical contact heterodimerization (Bouvier and
Hébert, 2014; Lambert and Javitch, 2014). GPCR dimerization
is still controversial, although many publications indicate
that research using these techniques they are evidence proof
of GPCRs dimerization (Gomes et al., 2016; Rico et al.,
2017).
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